11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases

11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases

Glucocorticoids (GCs), which are secreted by the adrenal cortex, are important regulators in the metabolism of carbohydrates, lipids, and proteins. For the proper functioning of the body, strict control of their release is necessary, as increased GCs levels may contribute to the development of obesi...

Full description

Bibliographic Details
Main Authors: Daria Kupczyk, Rafał Bilski, Mariusz Kozakiewicz, Renata Studzińska, Kornelia Kędziora-Kornatowska, Tomasz Kosmalski, Agnieszka Pedrycz-Wieczorska, Mariola Głowacka
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
11β-HSD enzyme
11β-HSD1 inhibitors
metabolic syndrome
glucocorticoids
diabetes mellitus
obesity
Online Access:https://www.mdpi.com/1422-0067/23/16/8984

Internet

https://www.mdpi.com/1422-0067/23/16/8984

Similar Items